on NeoPrediX
NeoPrediX Secures Investment From Springhood Ventures
FORT LAUDERDALE, FL / ACCESSWIRE / September 10, 2024 / NeoPrediX, a company specializing in predictive analytics for neonatal, maternal, and perinatal health, has received an investment from Springhood Ventures. This capital will expedite the development of NeoPrediX's solutions aimed at improving newborn outcomes globally.
Springhood Ventures focuses exclusively on children's health, investing in early-stage companies with strong commercial potential in the health sector. Their partnership with NeoPrediX underscores their dedication to advancing neonatal care and assisting startups from inception to impactful solutions.
Thorsten Waloschek, CEO of NeoPrediX, stated that this investment validates their approach and will help scale their efforts quicker. John Parker, Founder of Springhood Ventures, expressed enthusiasm for supporting NeoPrediX in expanding their portfolio, emphasizing the potential to transform children's health.
This collaboration marks a pivotal moment for both entities as they work towards delivering groundbreaking, evidence-based technology to improve neonatal health worldwide.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NeoPrediX news